Companies / LeonaBio, Inc.
LeonaBio, Inc.
Nasdaq: ATHALONACIK 1620463BOTHELL, WA
Financials
Ownership
9.4M shares outstanding · as of May 5, 2026
Ownership
| Insiders | 1.42% | 133,218 |
| Institutions | 63.90% | 6,002,558 |
| Public float | 34.68% | 3,257,738 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Litton Mark JamesCEOPRESIDENT and CEO · Director | 0.62% | 57,926 |
Church KevinCHIEF SCIENTIFIC OFFICER | 0.27% | 25,178 |
Worthington MarkGENERAL COUNSEL and CCO | 0.20% | 18,376 |
San Martin JavierCHIEF MEDICAL OFFICER | 0.17% | 15,887 |
Renninger RobertCHIEF FINANCIAL OFFICER | 0.17% | 15,851 |
Edelman JosephDirector | — | — |
Fluke John M JrDirector | — | — |
Johnson James aDirector | — | — |
Pickering GrantDirector | — | — |
Institutional holders 43
View all →| Holder | Value | % of shares |
|---|---|---|
| $19.11M | 19.79% | |
| $3.80M | 5.34% | |
| $3.52M | 4.94% | |
| $3.52M | 4.94% | |
| $3.35M | 4.94% | |
| $2.98M | 4.19% | |
| $2.98M | 4.19% | |
| $2.89M | 4.19% | |
| $1.16M | 1.64% | |
| $1.13M | 1.59% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Litton Mark James CEO | Sell | Common Stock | $27.7K | -5K -8.17% | 57,926 0.62% of shares | low |
| Jan 2, 2026 | Litton Mark James CEO | Sell | Common Stock | $17.8K | -3K -5.96% | 40,828 0.43% of shares | low |
| Jan 2, 2026 | San Martin Javier Executive | Sell | Common Stock | $11.3K | -2K -13.89% | 10,189 0.11% of shares | low |
| Mar 4, 2026 | San Martin Javier Executive | Sell | Common Stock | $9.2K | -2K -9.77% | 15,887 0.17% of shares | low |
| Mar 4, 2026 | Church Kevin Executive | Sell | Common Stock | $7.3K | -1K -5.12% | 25,178 0.27% of shares | low |
| Mar 4, 2026 | Worthington Mark Executive | Sell | Common Stock | $7.1K | -1K -6.74% | 18,376 0.20% of shares | low |
| Jan 2, 2026 | Church Kevin Executive | Sell | Common Stock | $6.0K | -876 -4.06% | 20,681 0.22% of shares | low |
| Jan 2, 2026 | Worthington Mark Executive | Sell | Common Stock | $6.0K | -876 -5.90% | 13,978 0.15% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Acorn Bioventures, L.P. | Passive13G/A | — |
| Baselake Partners, LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| LONA | Common Stock | 04746L203 |